Main caricature of Dorit Donoviel, who is speaking at HLTH and is Director at Translational Research Institute for Space Health Overlay caricature of Dorit Donoviel, who is speaking at HLTH and is Director at Translational Research Institute for Space Health

Dorit Donoviel

Director

Translational Research Institute for Space Health



As Director for the Translational Research Institute for Space Health (TRISH), Dorit Donoviel, Ph.D., leads a NASA-funded innovation R&D program that enables new health technologies to predict, protect and preserve astronaut health during deep space exploration missions. In her previous role as deputy chief scientist of the National Space Biomedical Research Institute (NSBRI), Dr. Donoviel led both domestic and international research programs that bridged academic, industry, and government resources to deliver fast and cost-effective tangible results. She is the recipient of multiple honors including recognition from the NASA Human Research Program and the NSBRI Pioneer Award.

Dr. Donoviel is Associate Professor in the Department of Pharmacology and Chemical Biology and the Center for Space Medicine at Baylor College of Medicine (BCM). Before joining BCM, she led metabolism drug discovery programs at Lexicon Pharmaceuticals for eight years. Dr. Donoviel completed a Human Frontiers postdoctoral fellowship at Mount Sinai Hospital in Toronto, Canada; holds a Biochemistry doctorate from the University of Washington in Seattle, WA; and received her baccalaureate degree in Biochemistry and Cell Biology from the University of California, San Diego in La Jolla, CA.

Session